Human Monocytes - CD14, CD16 - Ziegler-Heitbrock

Contact

Wnt5a inhibits human monocyte derived myeloid dendritic cell generation

Abstract

Wnt5a is a non-canonical Wnt protein that is expressed at elevated levels in inflammatory conditions. Its role in inflammation remains unclear, although it is known that Wnt5a is expressed at a higher level in monocyte-derived myeloid dendritic cells (Mo-mDCs) than in monocytes and macrophages. The function of Wnt5a in dendritic cells (DCs) remains relatively unexplored. Here, we found that under Mo-mDC culture conditions, Wnt5a inhibited the generation of CD14+/low Mo-mDCs while promoting the generation of CD14+/++ CD16+ monocytes. We could further show that stimulation of monocytes with rWnt5a induced a rapid IL-6 production and that the rWnt5a treated Mo-mDC differentiation was restored upon blocking of IL-6. Also conditioned media from Wnt5a stimulated human breast cancer cells producing IL-6, specifically inhibited Mo-mDC differentiation. These observations are strengthened by our finding that patients with sepsis, a disease involving elevated Wnt5a and IL-6 levels, also showed a significant increase in the CD14+ CD16++ /CD14+/++ CD16+ monocyte populations, which was accompanied by a significant decrease in circulating mDCs. We finally show that under typical Mo-mDC culture conditions, monocytes isolated from sepsis patients as compared to healthy controls, preferentially differentiated into CD14+/++ HLA-DR++ cells. We suggest that Wnt5a is a possible candidate mediator for the CD14+/++ CD16+ monocyte accumulation seen in infectious disease and cancer patients.

Authors: Bergenfelz C, Janols H, Wullt M, Jirström K, Bredberg A, Leandersson K
Journal: Scand J Immunol. . doi: 10.1111/sji.12075
Year: 2013
PubMed: Find in PubMed